Related Interviews

Stretched Valuations in Biotech Require Cautious Approach
December 15, 2014

Strong Fundamentals in Biotech Justify Even Higher Valuation Levels
December 11, 2014

Biotechnology Capital Inflows Reach Historic Highs
April 07, 2014

Increased Biotech Productivity and Innovation Reflected in FDA-Approved Drugs
August 23, 2013

High Success Rates and Significant M&A in the Antibody Space
April 16, 2013

FDA Approvals Accelerate and Opportunities Arise in Hepatitis C Market
April 08, 2013

Internet Interactivity Trends In 2011 - Brian J. Pitz - Ubs Investment Bank
April 04, 2011

A Long-only Strategy That Outperforms Down Markets - Donald Yacktman, Stephen Yacktman & Jason Subotky - Yacktman Asset Managem
November 15, 2010

A Close Look At Therapeutics Within Biotech - Matthew L. Kaplan - Ladenburg Thalmann & Co.
April 05, 2010

High-quality Companies With Excellent Growth Prospects - Joseph J. Costigan & Jeffrey M. Bagley - Davidson Trust Company
December 21, 2009

ALTERNATIVE ENERGY: INDUSTRY OVERVIEW - ROBERT W. STONE - COWEN AND COMPANY, LLC
November 10, 2008

INVESTING IN GROWTH STOCKS - WILLIAM F. DWYER - MTB INVESTMENT ADVISORS, INC.
August 11, 2008

INVESTING IN LARGE CAP VALUE STOCKS - BRUCE W. KASER - VOYAGEUR ASSET MANAGEMENT INC.
March 10, 2008

ROUNDTABLE FORUM: SEMICONDUCTOR EQUIPMENT
April 23, 2007

STEPHEN PATTEN - SECTORAL ASSET MANAGEMENT INC
February 27, 2006

L.FRIDAY / P.SWANSON - KING INVESTMENT ADVISORS INC
November 14, 2005

ROUNDTABLE FORUM: BIOTECHNOLOGY
June 27, 2005

DEPARTMENT STORES, DISCOUNTERS & DOLLAR STORES: SHARI EBERTS - J.P. MORGAN CHASE
April 05, 2004

RAJESH SHROTRIYA - SPECTRUM PHARMACEUTICALS INC (SPPI)
March 08, 2004

Office & Industrial Reits: David Fick - Legg Mason Wood Walker
August 18, 2003

L.holtz / Y.lipsker - Roger Engemann & Associates
July 28, 2003

Investing In Biotechnology: Mark Monane - Needham & Co
June 02, 2003

George Scangos - Exelixis Inc (exel)
June 02, 2003

Thomas Werthan - Emcore Corporation (emkr)
May 27, 2003

David Fried - Fried Asset Management Inc
December 16, 2002

Andrew Arbenz - Morgan Stanley Investment Management
November 18, 2002

Outlook For Regional Banks: Christopher Marinac - Suntrust Robinson Humphrey
April 14, 2002

Arthur Sands - Lexicon Genetics Inc (lexg)
October 12, 2001

Anthony Maramarco - David L. Babson & Company
October 01, 2001

Michael Wick - Telik Inc (telk)
September 14, 2001

Investing In Biotechnology: Panel, Prudential Vector Healthcare Group
December 18, 2000

Charles Knudsen Iii - The Ark Funds
October 02, 2000

Bill Bradley - Enlighten Software Solutions Inc (sftw)
January 31, 2000

Emerging Pharamaceutical Companies : Corey Davis - Chase H&q
January 13, 2000

Roundtable Forum: Major Chemicals
December 20, 1999

Scott Mercy - Lifepoint Hospitals Inc (lpnt)
December 02, 1999

Peter D. Meldrum - Myriad Genetics Inc (mygn)
December 14, 1998